Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: A single centre experience

European Radiology

Volumn 24, Issue 6, 2014, Pages 1339-1348

  Grieser, Christian ^a   Steffen, Ingo G ^a   Kramme, Incken Birthe ^a   Bläker, Hendrik ^a   Kilic, Ergin ^a   Fernandez, Carmen Maria Perez ^a   Seehofer, Daniel ^a   Schott, Eckart ^a   Hamm, Bernd ^a   Denecke, Timm ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

EOB; FNH; Gadoxetic acid; Hepatocellular adenoma; Liver MRI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; YOUNG ADULT;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; BIOPSY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; LIVER CIRCULATION; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84901676748     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3144-7     Document Type: Article

References (45)

1. van den Esschert JW, van Gulik TM, Phoa SS (2010) Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 27:46-55
2. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520-529
3. Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186-196 (Pubitemid 41535849)
4. Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509-522
5. Bioulac-Sage P, Cubel G, Taouji S, Scoazec JY, Leteurtre E, Paradis Vet al (2012) Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 36:1691-1699
6. Buscarini L, Fornari F, Bolondi L, Colombo P, Livraghi T, Magnolfi F et al (1990) Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol 11:344-348
7. Fornari F, Civardi G, Cavanna L, Di Stasi M, Rossi S, Sbolli G et al (1989) Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 24:949-955
8. Tsai JH, Jeng YM, Pan CC, Lu SW, Kuo YJ (2012) Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy. Pathology 44:605-610
9. Friedrich-Rust M, Klopffleisch T, Nierhoff J, Herrmann E, Vermehren J, Schneider MD et al (2013) Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int 33:739-755
10. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J (2006) Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 16:1873-1886 (Pubitemid 44193172)
11. van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172-181
12. Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166-177 (Pubitemid 40853309)
13. Morana G, Grazioli L, Kirchin MA, Bondioni MP, Faccioli N, Guarise A et al (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 46:225-239
14. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481-489
15. Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V et al (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26-34
16. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468-478 (Pubitemid 40139918)
17. Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36:686-696
18. Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 198:115-123
19. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J (2007) Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 13:2649-2654 (Pubitemid 46958719)
20. Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C (2008) Hepatocellular adenoma: what is new in 2008. Hepatol Int 2:316-321
21. Grieser C, Steffen I, Seehofer D, Kramme I, Uktolseya R, Scheurig-Muenkler C et al (2012) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid enhanced MRI characteristics. Magn Reson Imaging 31:755-760
22. Arrive L, Flejou JF, Vilgrain V, Belghiti J, Najmark D, Zins M et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507-512 (Pubitemid 24338341)
23. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342-357
24. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D (1995) Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165:303-308
25. Kim MJ, Rhee HJ, Jeong HT (2012) Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol 199:W575-W586
26. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME (1994) Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 163:113-116 (Pubitemid 24225698)
27. Ronot M, Paradis V, Duran R, Kerbaol A, Vullierme MP, Belghiti J et al (2013) MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23:914-923
28. Kacl GM, Hagspiel KD, Marincek B (1997) Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA. Abdom Imaging 22:264-267 (Pubitemid 27183627)
29. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740-748 (Pubitemid 47436120)
30. van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN (2011) Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 55:120-125
31. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515-524
32. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK (2009) MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 29:385-402
33. Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074-2082
34. Fujiwara H, Sekine S, Onaya H, Shimada K, Mikata R, Arai Y (2011) Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation. Jpn J Radiol 29:739-743
35. Eisenberg LB, Warshauer DM, Woosley JT, Cance WG, Bunzendahl H, Semelka RC (1995) CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 19:498-500
36. Huppertz A, Breuer J, Fels LM, Schultze-Mosgau M, Sutter G, Klein S et al (2011) Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP). J Magn Reson Imaging 33:409-416
37. Vander Borght S, Libbrecht L, Blokzijl H, Faber KN, Moshage H, Aerts R et al (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207:471-482 (Pubitemid 43025696)
38. Yoneda N, Matsui O, Kitao A, Kita R, Kozaka K, Koda W et al (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499-508
39. Denecke T, Steffen IG, Agarwal S, Seehofer D, Kroncke T, Hanninen EL et al (2012) Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 22:1769-1775
40. Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B (2012) Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR Am J Roentgenol 199:35-43
41. Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J (2012) Detection, classification, and characterization of focal liver lesions: value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 37:74-82
42. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504-511
43. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808-818
44. Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182-1191
45. Thomeer MG, Willemssen FE, Biermann KK, El Addouli H, de Man RA, Ijzermans JN et al (2013) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging. doi:10.1002/jmri.24281